Hugel Applies for FDA Approval of Botulax 50 and 100 Units
[Asia Economy Reporter Lee Seon-ae] Hugel announced on the 1st that it has applied for product approval from the U.S. Food and Drug Administration (FDA) for Botulax 50 units and 100 units.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Hugel stated, "We expect to confirm the efficacy and safety of Botulax (product name Letibotulinum Toxin A 50/100unit) for the improvement of moderate to severe glabellar lines," and added, "We plan to launch the product in the U.S. after obtaining product approval."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
